| Primary |
| Eye Pruritus |
28.5% |
| Eye Allergy |
11.0% |
| Seasonal Allergy |
9.0% |
| Hypersensitivity |
7.4% |
| Dry Eye |
6.4% |
| Off Label Use |
5.6% |
| Vitamin Supplementation |
4.7% |
| Ocular Hyperaemia |
4.6% |
| Lacrimation Increased |
3.5% |
| Hypertension |
2.9% |
| Product Used For Unknown Indication |
2.9% |
| Drug Use For Unknown Indication |
2.4% |
| Multiple Allergies |
2.4% |
| Eye Irritation |
2.0% |
| Keratoconjunctivitis Sicca |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Urticaria |
0.9% |
| Anxiety |
0.8% |
| Cardiac Disorder |
0.8% |
| Diabetes Mellitus |
0.8% |
|
| Eye Irritation |
20.1% |
| Instillation Site Pain |
19.0% |
| Drug Ineffective |
16.1% |
| Ocular Hyperaemia |
8.8% |
| Eye Pain |
5.7% |
| Instillation Site Irritation |
3.7% |
| Vision Blurred |
3.4% |
| Headache |
3.1% |
| Eye Pruritus |
2.8% |
| Drug Effect Decreased |
2.5% |
| Lacrimation Increased |
2.5% |
| Eyelid Oedema |
2.0% |
| Drug Hypersensitivity |
1.4% |
| Drug Ineffective For Unapproved Indication |
1.4% |
| Mydriasis |
1.4% |
| Rash |
1.4% |
| Condition Aggravated |
1.1% |
| Dry Eye |
1.1% |
| Epistaxis |
1.1% |
| Eye Swelling |
1.1% |
|
| Secondary |
| Eye Pruritus |
23.5% |
| Off Label Use |
12.4% |
| Lacrimation Increased |
10.5% |
| Dry Eye |
10.2% |
| Ocular Hyperaemia |
8.3% |
| Eye Allergy |
7.0% |
| Eye Irritation |
4.1% |
| Hypersensitivity |
3.3% |
| Keratoconjunctivitis Sicca |
3.1% |
| Seasonal Allergy |
2.8% |
| Anxiety |
1.7% |
| Conjunctivitis Allergic |
1.7% |
| Eyelid Margin Crusting |
1.7% |
| Dermatitis |
1.5% |
| Hypermetropia |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Eye Swelling |
1.3% |
| Stent Placement |
1.3% |
| Urticaria |
1.3% |
| Hypertension |
1.1% |
|
| Eye Irritation |
17.2% |
| Instillation Site Pain |
15.9% |
| Drug Ineffective |
13.4% |
| Eye Pain |
8.9% |
| Drug Ineffective For Unapproved Indication |
6.4% |
| Ocular Hyperaemia |
5.7% |
| Lacrimation Increased |
4.5% |
| Vision Blurred |
3.8% |
| Eye Pruritus |
3.2% |
| Headache |
3.2% |
| Drug Hypersensitivity |
2.5% |
| Abdominal Distension |
1.9% |
| Abnormal Sensation In Eye |
1.9% |
| Bacterial Infection |
1.9% |
| Eyelid Oedema |
1.9% |
| Incorrect Dose Administered |
1.9% |
| Mydriasis |
1.9% |
| Condition Aggravated |
1.3% |
| Epistaxis |
1.3% |
| Eyelid Pain |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.0% |
| Hypertension |
13.5% |
| Hypersensitivity |
7.9% |
| Anxiety |
4.5% |
| Dry Eye |
4.5% |
| Gastrooesophageal Reflux Disease |
4.5% |
| Osteoporosis |
4.5% |
| Back Pain |
3.4% |
| Blood Calcium Decreased |
3.4% |
| Blood Pressure Systolic Abnormal |
3.4% |
| Diabetes Mellitus |
3.4% |
| Dyspepsia |
3.4% |
| Metastatic Renal Cell Carcinoma |
3.4% |
| Musculoskeletal Pain |
3.4% |
| Psoriatic Arthropathy |
3.4% |
| Renal Cell Carcinoma |
3.4% |
| Seasonal Allergy |
3.4% |
| Supplementation Therapy |
3.4% |
| Type 2 Diabetes Mellitus |
3.4% |
| Cardiac Disorder |
2.2% |
|
| Bronchitis Chronic |
6.3% |
| Constipation |
6.3% |
| Depression |
6.3% |
| Inappropriate Schedule Of Drug Administration |
6.3% |
| Increased Upper Airway Secretion |
6.3% |
| Injection Site Pain |
6.3% |
| Muscle Spasms |
6.3% |
| Off Label Use |
6.3% |
| Pharyngeal Neoplasm |
6.3% |
| Pruritus |
6.3% |
| Pyrexia |
6.3% |
| Renal Failure |
6.3% |
| Septic Shock |
6.3% |
| Somnolence |
6.3% |
| Vertigo |
6.3% |
| Vision Blurred |
6.3% |
|
